The UK recommendation is 30g per day, but most adults already fall short
Gastrointestinal symptoms are the most common manifestations of tirzepatide overdose and may include: Severe nausea and vomiting : Often persistent and more intense than typical side effects, potentially leading to inability to retain fluids or medications Abdominal pain or cramping : May range from mild discomfort to severe pain, typically in the upper abdomen Diarrhea : Can contribute to dehydration and electrolyte imbalances Loss of appetite : Complete aversion to food, extending beyond normal appetite suppression Metabolic disturbances requiring medical attention: Hypoglycemia : Symptoms include trembling, sweating, rapid heartbeat, confusion, dizziness, hunger, irritability, and in severe cases, loss of consciousness or seizures
Nishi, A
Quality control considerations for the KLOW formulation include verification of individual peptide purity and identity, assessment of copper content and coordination in the GHK-Cu component, evaluation of peptide stability under storage conditions, and confirmation of biological activity for each component
The higher dose injectable form (Wegovy 2.4mg) produces more dramatic results